Related Experiment Video

Updated: May 24, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

A challenge to appropriate antibiotic use in children with respiratory infections: a 5-year single-institution

Ayumi Matsumoto1, Koichi Hashimoto, Yukihiko Kawasaki

  • 1Department of Pediatrics, Fukushima Medical University, Fukushima, Japan. b-walk@fmu.ac.jp

Fukushima Journal of Medical Science
|February 23, 2012
PubMed

Insights

Antibiotic-free treatment for pediatric respiratory infections effectively inhibited the emergence of antibiotic-resistant Streptococcus pneumoniae and Haemophilus influenzae, suggesting a safer approach to common colds.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Studied antibiotic resistance rates of Streptococcus pneumoniae and Haemophilus influenzae.
  • Examined antibiotic use in pediatric respiratory infection patients.
  • Investigated risks and benefits of antibiotic-free treatment.

Purpose of the Study:

  • Evaluate the necessity of antibiotics for pediatric respiratory syncytial virus (RSV) infections.
  • Test if antibiotic-free treatment reduces resistant S. pneumoniae strains.
  • Suggest improved treatment options for pediatric respiratory infections.

Main Methods:

  • Restricted antibiotic prescriptions for pediatric respiratory infection inpatients.
  • Compared rates of resistant S. pneumoniae and H. influenzae before and after intervention.
  • Analyzed host patient medication history.

Main Results:

  • Most RSV-infected patients recovered without antibiotics.
  • Antibiotic-free treatment inhibited the emergence of antibiotic-resistant strains.
  • Penicillin-resistant S. pneumoniae rates decreased; ampicillin-resistant H. influenzae rates showed no significant change.

Conclusions:

  • Patients with respiratory infections can be treated without antibiotics under careful observation.
  • Antibiotic-free strategies help inhibit the spread of resistant bacterial strains.
  • Monitoring and recommending antibiotic-free interventions are crucial for public health.
Abstract

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...